Johnson & Johnson to launch on TrumpRx with 4 of its prescription drugs

Johnson & Johnson to Market Four Medications on TrumpRx Website

Johnson & Johnson, a leading pharmaceutical company, is set to introduce four of its medications on the Trump administration’s TrumpRx website starting this Friday. This exclusive information was revealed by CBS News.

In January, the drug-making giant announced a voluntary agreement with the Trump administration aimed at reducing costs for Americans. As part of this agreement, Johnson & Johnson will provide Medicaid access to affordable prescriptions and market its drugs on TrumpRx. In return, the company will be exempt from the president’s tariff agenda.

Among the medications available on the discounted pharmaceutical site are metformin, a widely used prescription for Type 2 diabetes, as well as metformin extended relief, Invokana (another diabetes medication), and Xarelto (a blood thinner).

As part of its commitment, Johnson & Johnson had previously pledged to invest $55 billion in research and production facilities in Pennsylvania and North Carolina.

With the addition of Johnson & Johnson’s pharmaceuticals to the TrumpRx platform, the administration has significantly increased the number of drugs featured on the low-cost site since its initial launch in February.

It is important to note that the prescription drug prices listed on the site are specifically for patients who are uninsured or whose insurance does not cover the medication, requiring them to pay the full list price out of pocket. Individuals with insurance coverage typically have access to lower prices through their insurance plans.